corp_html/templates/rnd.tpl

<p><b>Research & Development at PLIVA</b></p>
<p><b>Vision</b></p>
<ul>
  <li>To become a leading company in anti-infective research</li>
  <li>To become an internationally recognized center for inflammation research</li>
  <li>To generate NMEs with the objective of producing commercial returns in line 
    with the PLIVA's growth targets</li>
  <li>To develop novel drugs which will serve as yet unmet medical needs at launch</li>
</ul>
<p align="center"><img src="p/Superrnd_ljudi_4.jpg" width="300" height="198"></p>
<p><b>Strategy</b></p>
<p>Within the last five years, PLIVA has been undergoing a vigorous process of 
  change to reshape its R&D operations in order to meet international standards 
  and future global challenges. PLIVA sees its continued R&D success as being 
  based on the combination of its international research team in Zagreb, a network 
  of strategic partnerships with multinational and biotech companies, and broad 
  co-operation with various international universities and institutes. In addition, 
  PLIVA's R&D locations at PLIVA Lachema (Brno, the Czech Republic) and PLIVA 
  Krakow (Krakow, Poland) give it unique access to experience and skills, particularly 
  in the development of NCEs and generics. Furthermore, local presence on the 
  developing markets of Central and Eastern Europe will give PLIVA a competitive 
  advantage in the development and registration of its products.</p>
<p>At its main research location in Zagreb, PLIVA maintains all the necessary 
  technology for synthetic chemistry, structure based drug design, molecular biology, 
  pharmacology, toxicology, process development and pharmaceutical technology. 
  This enables accurate evaluation of compounds and research proposals at early 
  stages and allows more rapid movement toward clinical development. In general, 
  PLIVA is looking to bring projects from the Discovery stage to Phase II clinical 
  trials, thereafter seeking a partner for global development and marketing.</p>
1	dpavlin	1.2	<p><b>Research & Development at PLIVA</b></p>
2			<p><b>Vision</b></p>
3			<ul>
4			<li>To become a leading company in anti-infective research</li>
5			<li>To become an internationally recognized center for inflammation research</li>
6			<li>To generate NMEs with the objective of producing commercial returns in line
7			with the PLIVA's growth targets</li>
8			<li>To develop novel drugs which will serve as yet unmet medical needs at launch</li>
9			</ul>
10			<p align="center"><img src="p/Superrnd_ljudi_4.jpg" width="300" height="198"></p>
11			<p><b>Strategy</b></p>
12			<p>Within the last five years, PLIVA has been undergoing a vigorous process of
13			change to reshape its R&D operations in order to meet international standards
14			and future global challenges. PLIVA sees its continued R&D success as being
15			based on the combination of its international research team in Zagreb, a network
16			of strategic partnerships with multinational and biotech companies, and broad
17			co-operation with various international universities and institutes. In addition,
18			PLIVA's R&D locations at PLIVA Lachema (Brno, the Czech Republic) and PLIVA
19			Krakow (Krakow, Poland) give it unique access to experience and skills, particularly
20			in the development of NCEs and generics. Furthermore, local presence on the
21			developing markets of Central and Eastern Europe will give PLIVA a competitive
22			advantage in the development and registration of its products.</p>
23			<p>At its main research location in Zagreb, PLIVA maintains all the necessary
24			technology for synthetic chemistry, structure based drug design, molecular biology,
25			pharmacology, toxicology, process development and pharmaceutical technology.
26			This enables accurate evaluation of compounds and research proposals at early
27			stages and allows more rapid movement toward clinical development. In general,
28			PLIVA is looking to bring projects from the Discovery stage to Phase II clinical
29			trials, thereafter seeking a partner for global development and marketing.</p>